Bank of New York Mellon’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bank of New York Mellon’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,834	Closed	-$61K	–	4586
2022 Q3	$61K	Buy	+10,834	New	+$67.9K	﹤0.01%	4293
2022 Q2	–	Sell	-39,209	Closed	-$456K	–	4747
2022 Q1	$456K	Buy	39,209 +2,448	+7%	+$29.1K	﹤0.01%	3764
2021 Q4	$672K	Buy	36,761 +569	+2%	+$7.22K	﹤0.01%	3613
2021 Q3	$428K	Buy	36,192 +2,331	+7%	+$34K	﹤0.01%	3898
2021 Q2	$582K	Buy	33,861 +12,834	+61%	+$244K	﹤0.01%	3701
2021 Q1	$385K	Sell	21,027 -2,001	-9%	-$42K	﹤0.01%	3823
2020 Q4	$434K	Buy	23,028 +1,272	+6%	+$27.4K	﹤0.01%	3686
2020 Q3	$459K	Buy	21,756 +2,736	+14%	+$64K	﹤0.01%	3534
2020 Q2	$549K	Sell	19,020 -1,052	-5%	-$31.7K	﹤0.01%	3427
2020 Q1	$703K	Buy	20,072 +9,567	+91%	+$310K	﹤0.01%	3202
2019 Q4	$257K	Buy	+10,505	New	+$184K	﹤0.01%	3847

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of New York Mellon's OYST Position: Q4 2022 in Review

Bank of New York Mellon sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 10,834 shares — an estimated $61K sold.

Bank of New York Mellon first reported a position in OYST in Q4 2019 and held it in 11 quarters. The position peaked at $703K in Q1 2020. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

Bank of New York Mellon reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bank of New York Mellon sold 10,834 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $61K.
Bank of New York Mellon first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
Bank of New York Mellon's Oyster Point Pharma, Inc. Common Stock position peaked at $703K in Q1 2020.
53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.